Locacorten-Vioform

País: Nueva Zelanda

Idioma: inglés

Fuente: Medsafe (Medicines Safety Authority)

Ingredientes activos:

Clioquinol 1%{relative};  ; Flumetasone pivalate 0.02%{relative}

Disponible desde:

AFT Pharmaceuticals Ltd

Designación común internacional (DCI):

Clioquinol 1% w/v

formulario farmacéutico:

Ear drops

Composición:

Active: Clioquinol 1%{relative}   Flumetasone pivalate 0.02%{relative} Excipient: Macrogol 300

Unidades en paquete:

Bottle, dropper, PE dropper bottle and plastic cap x 7.5mL, 7.5 mL

clase:

Prescription

tipo de receta:

Prescription

Fabricado por:

Synthexim

indicaciones terapéuticas:

Eczema of the external auditory meatus in which secondary infection with microorganisms sensitive to clioquinol has occurred. · Otitis externa · Otomycosis.

Resumen del producto:

Package - Contents - Shelf Life: Bottle, dropper, PE dropper bottle and plastic cap x 7.5mL - 7.5 mL - 18 months from date of manufacture stored at or below 25°C

Fecha de autorización:

2010-05-06

Ficha técnica

Page 1 of 9
NEW ZEALAND DATA SHEET
1.
LOCACORTEN-VIOFORM
® (1% CLIOQUINOL AND 0.02% FLUMETASONE
PIVALATE EAR DROPS)
LOCACORTEN-VIOFORM
®
1% clioquinol and 0.02% flumetasone pivalate ear drops
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
LOCACORTEN-VIOFORM
®
contains
1% clioquinol and 0.02% flumetasone pivalate.
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Ear drops.
A clear yellowish solution with a volume of 7.5ml (32 ± 3 drops per
1ml). Flumetasone is a
synthetic difluorinated glucocorticoid.
Clioquinol is a halogenated hydroxyquinolone derivative.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Eczema of the external auditory meatus in which secondary infection
with micro-organisms sensitive
to clioquinol has occurred.
•
Otitis externa
•
Otomycosis.
4.2
DOSE AND METHOD OF ADMINISTRATION
Before application, the auditory meatus should be cleansed and dried
carefully.
Instill 2 or 3 drops twice daily into the auditory meatus by gently
squeezing the plastic bottle. The
patient should be either sitting or lying down with the treated ear
turned upwards during application.
This position should be maintained for at least 1-2 minutes following
the application.
Alternatively, a gauze or cotton wick saturated with the solution may
be inserted into the ear canal.
Keep the wick moistened by adding further solution. It should be
replaced at least once every 24
hours.
The solution may be warmed to body temperature prior to each
application (e.g. by holding the bottle
Page 2 of 9
in the hands). Heating above body temperature should be avoided.
Contamination of the dropper with
material from the ear, fingers, or other sources should be avoided.
Treatment should normally not
exceed 10 days.
LOCACORTEN-VIOFORM
®
is dissolved in a polyethylene glycol vehicle which forms an inert,
non-
irritant, rather viscous medium. This medium has a softening effect on
the cerumen and does not
prevent drainage, thus ensures prolonged contact of the active
ingredients with the surface of the ear
canal.
If no